Alerts will be sent to your verified email
Verify Email
RPGLIFE
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
RPG Life Sciences is a research-based pharmaceutical company under RPG Enterprises. It operates in Branded Formulations, Global Generics, and Synthetic APIs markets, producing a wide range of quality and affordable medicines.
RPG Life Sciences major competitors are Advanced Enzyme, Orchid Pharma, Gufic Biosciences, Zota Health Care, Guj. Themis Biosyn, Dishman Carbogen Amc, Unichem Lab.
Market Cap of RPG Life Sciences is ₹3,863 Crs.
While the median market cap of its peers are ₹3,667 Crs.
RPG Life Sciences seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Mar Jul | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Sep | Jun Sep Dec | Mar | ||||||||||
| Investor Presentation | Apr Jun Jul | Mar Jun Sep Dec | Jan Mar Jun Sep Dec | Mar Apr Jun Aug Sep Dec | Jan Mar Jun Sep Dec | Mar | Mar Jun | Mar Jun Sep | Mar Sep | |||||||||
| Conference Call | Mar Jun Sep | Mar Sep | Mar Sep | Sep | ||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
